4//SEC Filing
Forte Steve 4
Accession 0001415889-24-009255
CIK 0001808158other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 6:59 PM ET
Size
9.3 KB
Accession
0001415889-24-009255
Insider Transaction Report
Form 4
Forte Steve
EVP, CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Shares
2024-03-25$4.79/sh−825$3,952→ 43,862 total - Sale
Common Shares
2024-03-26$4.60/sh−825$3,795→ 43,037 total - Sale
Common Shares
2024-03-27$4.62/sh−825$3,812→ 42,212 total
Footnotes (4)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 22, 2023. On January 30, 2023, the holder was granted 24,530 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on February 1, 2023, of which 8,177 of these RSUs vested on January 30, 2024. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.72 to $4.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.83 inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.73 inclusive.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
Related Parties
1- filerCIK 0001815428
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 6:59 PM ET
- Size
- 9.3 KB